Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 5INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 1

Conditions

Cushing Syndrome 4ACTH Syndrome, Ectopic 4Pituitary Diseases 3Pituitary ACTH Hypersecretion 3Leiomyoma 2Hirsutism 2Choristoma 2Adrenal Cortex Neoplasms 2Uterine Hemorrhage 1Sarcoma 1Prostatic Neoplasms 1Ovarian Neoplasms 1Carcinoma, Transitional Cell 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

telapristone acetate 18vilaprisan 12relugolix 11estradiol, norethindrone drug combination 9asoprisnil 9Estradiol 8elagolix 7Uterine Myomectomy 7ulipristal acetate 6Norethindrone Acetate 6Leuprolide 5linzagolix 4Uterine Artery Embolization 3Sugars 3ulipristal 2Progestins 2Mifepristone 2epigallocatechin gallate 1carbetocin 1Vitamin D 1Vitamin B 6 1Therapeutics 1Standard of Care 1Sodium Chloride 1Robotic Surgical Procedures 1Radiofrequency Ablation 1Progesterone 1Microbial Collagenase 1Megestrol Acetate 1Medroxyprogesterone Acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Leiomyoma × Mifepristone × Clear all
NCT03210324 2019-08-07

A Study on the Mifepristone Tablets in the Treatment of Symptomatic Uterine Fibroids With Safety and Efficacy

China Resources Zizhu Pharmaceutical Co., Ltd.

Phase 4 Terminated
434 enrolled

Leiomyoma

NCT00881140 2012-12-19

Efficacy Study of Vaginal Mifepristone to Treat Uterine Fibroids

BioPro Medical Ltd

Phase 2 Completed
30 enrolled
Gynecologic

Leiomyoma, Uterine Hemorrhage

Data powered by HemOnc (CC BY 4.0) Colophon âš¡